LifeMD Debt to Equity Ratio 2011-2023 | LFMD
Current and historical debt to equity ratio values for LifeMD (LFMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. LifeMD debt/equity for the three months ending December 31, 2023 was 3.22.
| LifeMD Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.05B | $0.01B | 9.51 |
| 2023-09-30 | $0.05B | $-0.01B | -4.67 |
| 2023-06-30 | $0.05B | $-0.01B | -4.47 |
| 2023-03-31 | $0.04B | $-0.01B | -5.60 |
| 2022-12-31 | $0.03B | $-0.01B | -4.51 |
| 2022-09-30 | $0.03B | $0.00B | 9.82 |
| 2022-06-30 | $0.03B | $0.01B | 4.57 |
| 2022-03-31 | $0.03B | $0.02B | 2.08 |
| 2021-12-31 | $0.02B | $0.03B | 0.93 |
| 2021-09-30 | $0.03B | $-0.02B | -2.12 |
| 2021-06-30 | $0.03B | $-0.01B | -3.99 |
| 2021-03-31 | $0.02B | $-0.00B | -23.28 |
| 2020-12-31 | $0.01B | $-0.00B | -17.31 |
| 2020-09-30 | $0.01B | $-0.01B | -1.68 |
| 2020-06-30 | $0.01B | $-0.01B | -1.62 |
| 2020-03-31 | $0.01B | $-0.00B | -1.62 |
| 2019-12-31 | $0.01B | $-0.00B | -4.05 |
| 2019-09-30 | $0.00B | $-0.00B | -5.48 |
| 2019-06-30 | $0.00B | $-0.00B | -2.54 |
| 2019-03-31 | $0.00B | $0.00B | 10.81 |
| 2018-12-31 | $0.00B | $0.00B | 2.19 |
| 2018-09-30 | $0.00B | $0.00B | 0.58 |
| 2018-06-30 | $0.00B | $0.00B | 0.39 |
| 2018-03-31 | $0.00B | $0.00B | 0.36 |
| 2017-12-31 | $0.00B | $0.00B | 1.03 |
| 2017-09-30 | $0.00B | $0.00B | 1.39 |
| 2017-06-30 | $0.00B | $0.00B | -3.67 |
| 2017-03-31 | $0.00B | $-0.00B | -1.81 |
| 2016-12-31 | $0.00B | $0.00B | -3.18 |
| 2016-09-30 | $0.00B | $0.00B | 1.36 |
| 2016-06-30 | $0.00B | $0.00B | 1.52 |
| 2016-03-31 | $0.00B | $0.00B | 2.14 |
| 2015-12-31 | $0.00B | $0.00B | 1.48 |
| 2015-09-30 | $0.00B | $0.00B | -2.79 |
| 2015-06-30 | $0.00B | $0.00B | -2.52 |
| 2015-03-31 | $0.00B | $0.00B | -2.59 |
| 2014-12-31 | $0.00B | $0.00B | -2.26 |
| 2014-09-30 | $0.00B | $0.00B | -11.31 |
| 2014-06-30 | $0.00B | $0.00B | 19.83 |
| 2014-03-31 | $0.00B | $0.00B | 2.97 |
| 2013-12-31 | $0.00B | $0.00B | 1.82 |
| 2013-09-30 | $0.00B | $0.00B | 6.18 |
| 2013-06-30 | $0.00B | $0.00B | 1.56 |
| 2013-03-31 | $0.00B | $0.00B | 2.03 |
| 2012-12-31 | $0.00B | $0.00B | 1.74 |
| 2012-09-30 | $0.00B | $0.00B | 0.00 |
| 2012-06-30 | $0.00B | $0.00B | 0.00 |
| 2012-03-31 | $0.00B | $0.00B | 0.00 |
| 2011-12-31 | $0.00B | $0.00B | -2.21 |
| 2010-12-31 | $0.00B | $-0.00B | -1.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.437B | $0.153B |
| LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.431B | 15.74 |
| Cencora (COR) | United States | $47.828B | 19.09 |
| ICON (ICLR) | Ireland | $24.755B | 23.37 |
| DiDi Global (DIDIY) | China | $23.950B | 0.00 |
| Avantor (AVTR) | United States | $17.059B | 23.50 |
| Viatris (VTRS) | United States | $13.760B | 3.93 |
| CochLear (CHEOY) | $13.446B | 0.00 | |
| Revvity (RVTY) | United States | $12.611B | 21.95 |
| Medpace Holdings (MEDP) | United States | $12.076B | 39.73 |
| Charles River Laboratories (CRL) | United States | $11.735B | 21.39 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.550B | 0.00 |
| Natera (NTRA) | United States | $11.158B | 0.00 |
| Solventum (SOLV) | United States | $10.666B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.782B | 50.67 |
| Bausch + Lomb (BLCO) | Canada | $5.187B | 19.95 |
| Organon (OGN) | United States | $4.709B | 4.56 |
| Doximity (DOCS) | United States | $4.401B | 32.76 |
| PACS (PACS) | United States | $3.643B | 0.00 |
| Sotera Health (SHC) | United States | $3.204B | 15.72 |
| Surgery Partners (SGRY) | United States | $3.145B | 29.22 |
| Progyny (PGNY) | United States | $3.124B | 52.42 |
| GoodRx Holdings (GDRX) | United States | $2.797B | 141.60 |
| Life Times (LTH) | United States | $2.776B | 30.67 |
| Premier (PINC) | United States | $2.493B | 9.13 |
| Teladoc Health (TDOC) | United States | $2.257B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.131B | 6.89 |
| Agilon Health (AGL) | United States | $2.109B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.782B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.316B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.975B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.748B | 7.74 |
| Embecta (EMBC) | United States | $0.599B | 3.95 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
| Enhabit (EHAB) | United States | $0.495B | 44.86 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.487B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.438B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| Beauty Health (SKIN) | United States | $0.378B | 0.00 |
| MultiPlan (MPLN) | United States | $0.368B | 0.00 |
| DocGo (DCGO) | United States | $0.364B | 58.17 |
| ModivCare (MODV) | United States | $0.340B | 4.51 |
| Sera Prognostics (SERA) | United States | $0.335B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.291B | 0.00 |
| Sharecare (SHCR) | United States | $0.266B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.256B | 0.00 |
| Biodesix (BDSX) | United States | $0.145B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.076B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.032B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.015B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |